A health economic model for evaluating a vaccine for the prevention of herpes zoster and post-herpetic neuralgia in the UK

BACKGROUND: A live-attenuated vaccine aimed at preventing herpes zoster (HZ) and its main complication, post-herpetic neuralgia (PHN) is available in Europe for immunocompetent adults aged 50 years and more. The study objective is to assess the cost effectiveness of a vaccination program for this po...

Descripción completa

Detalles Bibliográficos
Autores principales: Moore, Lee, Remy, Vanessa, Martin, Monique, Beillat, Maud, McGuire, Alistair
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2881001/
https://www.ncbi.nlm.nih.gov/pubmed/20433704
http://dx.doi.org/10.1186/1478-7547-8-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2881001/
https://www.ncbi.nlm.nih.gov/pubmed/20433704
http://dx.doi.org/10.1186/1478-7547-8-7

Ejemplares similares